What is the address of DR. JEF DESIMPELAERE, RADIOLOGIE?

The registered office of DR. JEF DESIMPELAERE, RADIOLOGIE is located at Kruisbeeldstraat 86, 9220 Hamme (Vl.).

Is DR. JEF DESIMPELAERE, RADIOLOGIE still active?

Yes. According to the CBE (30 September 2026) DR. JEF DESIMPELAERE, RADIOLOGIE is active, legal situation “Normale toestand”, started on 14 January 2019.

Is DR. JEF DESIMPELAERE, RADIOLOGIE registered on Peppol?

No, DR. JEF DESIMPELAERE, RADIOLOGIE is currently not registered on the Peppol network.

What is the enterprise number of DR. JEF DESIMPELAERE, RADIOLOGIE?

The enterprise number of DR. JEF DESIMPELAERE, RADIOLOGIE is BE0718619352.

When was DR. JEF DESIMPELAERE, RADIOLOGIE founded?

DR. JEF DESIMPELAERE, RADIOLOGIE was founded on 14 January 2019.

Who are the directors of DR. JEF DESIMPELAERE, RADIOLOGIE?

According to the 2025 annual accounts, the directors of DR. JEF DESIMPELAERE, RADIOLOGIE are: Jef Desimpelaere.

Is DR. JEF DESIMPELAERE, RADIOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 January 2019; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. JEF DESIMPELAERE, RADIOLOGIE make in 2025?

DR. JEF DESIMPELAERE, RADIOLOGIE posted a profit after taxes of € 395,031 in financial year 2025.

What is the revenue of DR. JEF DESIMPELAERE, RADIOLOGIE?

As a small company, DR. JEF DESIMPELAERE, RADIOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 537,100.

DR. JEF DESIMPELAERE, RADIOLOGIE (Private Limited)

Dossier DR. JEF DESIMPELAERE, RADIOLOGIE, printed on 30 September 2026 from databakkes.be/en/0718619352/dr-jef-desimpelaere-radiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR. JEF DESIMPELAERE, RADIOLOGIE from Hamme (Vl.), company number BE0718619352, closed financial year 2025 with a result of € 395,031 after tax. For that financial year DR. JEF DESIMPELAERE, RADIOLOGIE recorded a gross margin of € 537,100 and equity of € 19,465. Compared with financial year 2024, the result moved from € 359,864 to € 395,031. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on January 22, 2026.

What it is worth Growing

€ 19,465

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 395,031

▲ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 329,406

▲ 54% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 395,000 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 23,343

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 25,196

▼ 29% vs 2024

€ 10,505 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 1,160

▼ 36% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 61,113

▼ 10% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 353,235 Gross margin 2022: € 353,235 First fiscal year in the series	€ 436,792 Gross margin 2023: € 436,792 ▲ 24% vs 2022 (€ 353,235) Favourable step	€ 488,614 Gross margin 2024: € 488,614 ▲ 12% vs 2023 (€ 436,792) Favourable step	€ 537,100 Gross margin 2025: € 537,100 ▲ 10% vs 2024 (€ 488,614) Favourable step	▲ 10%
Profit after taxes	€ 265,171 Profit after taxes 2022: € 265,171 First fiscal year in the series	€ 322,008 Profit after taxes 2023: € 322,008 ▲ 21% vs 2022 (€ 265,171) Favourable step	€ 359,864 Profit after taxes 2024: € 359,864 ▲ 12% vs 2023 (€ 322,008) Favourable step	€ 395,031 Profit after taxes 2025: € 395,031 ▲ 10% vs 2024 (€ 359,864) Favourable step	▲ 10%
Equity	€ 804,563 Equity 2022: € 804,563 First fiscal year in the series	€ 804,570 Equity 2023: € 804,570 Unchanged (€ 804,563) Favourable step	€ 19,434 Equity 2024: € 19,434 ▼ 98% vs 2023 (€ 804,570) Unfavourable step	€ 19,465 Equity 2025: € 19,465 Unchanged (€ 19,434) Favourable step
Total debts	€ 121,582 Total debts 2022: € 121,582 First fiscal year in the series	€ 422,898 Total debts 2023: € 422,898 ▲ 248% vs 2022 (€ 121,582) Unfavourable step	€ 448,539 Total debts 2024: € 448,539 ▲ 6% vs 2023 (€ 422,898) Unfavourable step	€ 466,091 Total debts 2025: € 466,091 ▲ 4% vs 2024 (€ 448,539) Unfavourable step	▲ 4%
Cash	€ 706,427 Cash 2022: € 706,427 First fiscal year in the series	€ 950,585 Cash 2023: € 950,585 ▲ 35% vs 2022 (€ 706,427) Favourable step	€ 214,519 Cash 2024: € 214,519 ▼ 77% vs 2023 (€ 950,585) Unfavourable step	€ 329,406 Cash 2025: € 329,406 ▲ 54% vs 2024 (€ 214,519) Favourable step	▲ 54%
Retained profit	€ 785,963 Retained profit 2022: € 785,963 First fiscal year in the series	€ 785,970 Retained profit 2023: € 785,970 Unchanged (€ 785,963) Favourable step	€ 834 Retained profit 2024: € 834 ▼ € 785,136 vs 2023 (€ 785,970) Unfavourable step	€ 865 Retained profit 2025: € 865 ▲ 4% vs 2024 (€ 834) Favourable step	▲ 4%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 322,000 Dividend 2023: € 322,000 Unchanged (€ 0) Unchanged	€ 1,145,000 Dividend 2024: € 1,145,000 ▲ 256% vs 2023 (€ 322,000) Unchanged	€ 395,000 Dividend 2025: € 395,000 ▼ 66% vs 2024 (€ 1,145,000) Unchanged	▼ 66%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 44,963 Bank debt 2023: € 44,963 Unchanged (€ 0) Unfavourable step	€ 35,281 Bank debt 2024: € 35,281 ▼ 22% vs 2023 (€ 44,963) Favourable step	€ 25,196 Bank debt 2025: € 25,196 ▼ 29% vs 2024 (€ 35,281) Favourable step	▼ 29%
Balance sheet total	€ 926,144 Balance sheet total 2022: € 926,144 First fiscal year in the series	€ 1,227,468 Balance sheet total 2023: € 1,227,468 ▲ 33% vs 2022 (€ 926,144) Unchanged	€ 467,973 Balance sheet total 2024: € 467,973 ▼ 62% vs 2023 (€ 1,227,468) Unchanged	€ 485,556 Balance sheet total 2025: € 485,556 ▲ 4% vs 2024 (€ 467,973) Unchanged	▲ 4%

Key figures of DR. JEF DESIMPELAERE, RADIOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to DR. JEF DESIMPELAERE, RADIOLOGIE?

What happened at DR. JEF DESIMPELAERE, RADIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 22, 2026 New annual accounts for financial year 2025: profit of € 395,031 (▲ 10% vs 2024). Source: NBB ↗
Jan 14, 2019 New establishment in Antwerpen. KBO
Jan 14, 2019 Start of the company according to the CBE. KBO
2019 Jef Desimpelaere became a director. NBB

In short

From € 265,171 profit in 2022 to € 395,031 profit in 2025.

Paid € 423,586 in corporate taxes since 2022.

Best year ever: 2025, with € 395,031 profit.

Paid out € 1.9 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. JEF DESIMPELAERE, RADIOLOGIE? We notify you, reason included.

Follow DR. JEF DESIMPELAERE, RADIOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jef Desimpelaere

DR. JEF DESIMPELAERE, RADIOLOGIE

Behind DR. JEF DESIMPELAERE, RADIOLOGIE is Jef Desimpelaere.

See the full network in the app

Directors

According to the 2025 annual accounts

Jef Desimpelaere

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Kruisbeeldstraat 86

9220 Hamme (Vl.)

2.283.886.675

Lindendreef 1

2020 Antwerpen

Active since 14 January 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0718.619.352
VAT number: BE 0718.619.352
Registered office: Kruisbeeldstraat 86, 9220 Hamme (Vl.)
Names & denominations: DR. JEF DESIMPELAERE, RADIOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 14 January 2019
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗